Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

National Institutes of Health

Federal funding opportunity PAR-25-211 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.